Resveratrol and its synthetic derivatives exert opposite effects on mesothelial cell-dependent angiogenesis via modulating secretion of VEGF and IL-8/CXCL8

Angiogenesis

Volumn 15, Issue 3, 2012, Pages 361-376

  Mikuła Pietrasik, Justyna ^a   Kuczmarska, Angelika ^a   Kucińska, Małgorzata ^a   Murias, Marek ^a   Wierzchowski, Marcin ^a   Winckiewicz, Marek ^a   Staniszewski, Ryszard ^a   Bręborowicz, Andrzej ^a   Książek, Krzysztof ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Angiogenesis; Endothelial cells; Mesothelial cells; Resveratrol; Stilbenes

Indexed keywords

3,3',4,4' TETRAHYDROXY TRANS STILBENE; 3,3',4,4',5,5' HEXAHYDROXY TRANS STILBENE; CXCL1 CHEMOKINE; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUTRALIZING ANTIBODY; REACTIVE OXYGEN METABOLITE; RESVERATROL; STILBENE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL AGING; CELL PROLIFERATION; CELL SPECIFICITY; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFICACY; DRUG EXPOSURE; DRUG STRUCTURE; GROWTH INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MESOTHELIUM CELL; MICROVASCULAR ENDOTHELIAL CELL; MIGRATION INHIBITION; PERITONEAL DISEASE; PERITONEUM CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; UMBILICAL VEIN ENDOTHELIAL CELL;

EID: 84865118882     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-012-9266-0     Document Type: Article

References (59)

1. Strobel T, Cannistra SA (1999) Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro. Gynecol Oncol 73:362-367 (Pubitemid 29272856)
2. Lessan K, Aguiar DJ, Oegema T, Siebenson L, Skubitz AP (1999) CD44 and beta1 integrin mediate ovarian carcinoma cell adhesion to peritoneal mesothelial cells. Am J Pathol 154:1525-1537 (Pubitemid 29226447)
3. Folkman J (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 82:4-6 (Pubitemid 20020880)
4. Gerber SA, Rybalko VY, Bigelow CE, Lugade AA, Foster TH, Frelinger JG, Lord EM (2006) Preferential attachment of peritoneal tumor metastases to omental immune aggregates and possible role of a unique vascular microenvironment in metastatic survival and growth. Am J Pathol 169:1739-1752 (Pubitemid 351182005)
5. Ksiazek K, Mikula-Pietrasik J, Jorres A, Witowski J (2008) Oxidative stress-mediated early senescence contributes to the short replicative life span of human peritoneal mesothelial cells. Free Radic Biol Med 45:460-467
6. Ksiazek K, Mikula-Pietrasik J, Korybalska K, Dworacki G, Jorres A, Witowski J (2009) Senescent peritoneal mesothelial cells promote ovarian cancer cell adhesion: the role of oxidative stress-induced fibronectin. Am J Pathol 174:1230-1240
7. Ksiazek K, Mikula-Pietrasik J, Catar R, Dworacki G, Winckiewicz M, Frydrychowicz M, Dragun D, Staniszewski R, Jorres A, Witowski J (2010) Oxidative stress-dependent increase in ICAM-1 expression promotes adhesion of colorectal and pancreatic cancers to the senescent peritoneal mesothelium. Int J Cancer 127:293-303
8. Ksiazek K, Jorres A, Witowski J (2008) Senescence induces a proangiogenic switch in human peritoneal mesothelial cells. Rejuvenation Res 11:681-683 (Pubitemid 351931479)
9. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y (2004) Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res 24:2783-2840 (Pubitemid 39409568)
10. Rezk YA, Balulad SS, Keller RS, Bennett JA (2006) Use of resveratrol to improve the effectiveness of cisplatin and doxorubicin: study in human gynecologic cancer cell lines and in rodent heart. Am J Obstet Gynecol 194:e23-e26
11. Chen Y, Tseng SH (2007) Review. Pro- and anti-angiogenesis effects of resveratrol. In Vivo 21:365-370 (Pubitemid 46534292)
12. Kaga S, Zhan L, Matsumoto M, Maulik N (2005) Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 39:813-822 (Pubitemid 41464418)
13. Robich MP, Osipov RM, Nezafat R, Feng J, Clements RT, Bianchi C, Boodhwani M, Coady MA, Laham RJ, Sellke FW (2010) Resveratrol improves myocardial perfusion in a swine model of hypercholesterolemia and chronic myocardial ischemia. Circulation 122:S142-S149
14. Srivastava RK, Unterman TG, Shankar S (2010) FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol. Mol Cell Biochem 337:201-212
15. Kimura Y, Sumiyoshi M, Baba K (2008) Antitumor activities of synthetic and natural stilbenes through antiangiogenic action. Cancer Sci 99:2083-2096
16. Garvin S, Ollinger K, Dabrosin C (2006) Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo. Cancer Lett 231:113-122 (Pubitemid 41779459)
17. Chen JC, Chen Y, Lin JH, Wu JM, Tseng SH (2006) Resveratrol suppresses angiogenesis in gliomas: evaluation by color Doppler ultrasound. Anticancer Res 26:1237-1245
18. Murias M, Jager W, Handler N, Erker T, Horvath Z, Szekeres T, Nohl H, Gille L (2005) Antioxidant, prooxidant and cytotoxic activity of hydroxylated resveratrol analogues: structure-activity relationship. Biochem Pharmacol 69:903-912 (Pubitemid 40312708)
19. Murias M, Handler N, Erker T, Pleban K, Ecker G, Saiko P, Szekeres T, Jager W (2004) Resveratrol analogues as selective cyclooxygenase-2 inhibitors: synthesis and structure-activity relationship. Bioorg Med Chem 12:5571-5578 (Pubitemid 39304056)
20. Murias M, Miksits M, Aust S, Spatzenegger M, Thalhammer T, Szekeres T, Jaeger W (2008) Metabolism of resveratrol in breast cancer cell lines: impact of sulfotransferase 1A1 expression on cell growth inhibition. Cancer Lett 261:172-182
21. Yung S, Li FK, Chan TM (2006) Peritoneal mesothelial cell culture and biology. Perit Dial Int 26:162-173 (Pubitemid 44336164)
22. Witowski J, Korybalska K, Wisniewska J, Breborowicz A, Gahl GM, Frei U, Passlick-Deetjen J, Jorres A (2000) Effect of glucose degradation products on human peritoneal mesothelial cell function. J Am Soc Nephrol 11:729-739 (Pubitemid 30171882)
23. Kim S, Bell K, Mousa SA, Varner JA (2000) Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol 156:1345-1362 (Pubitemid 30660012)
24. Mizukami Y, Jo WS, Duerr EM, Gala M, Li J, Zhang X, Zimmer MA, Iliopoulos O, Zukerberg LR, Kohgo Y, Lynch MP, Rueda BR, Chung DC (2005) Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med 11:992-997 (Pubitemid 41294446)
25. Shibata T, Imaizumi T, Matsumiya T, Tamo W, Hatakeyama M, Yoshida H, Munakata H, Fukuda I, Satoh K (2003) Effect of MG132, a proteasome inhibitor, on the expression of growth related oncogene protein-alpha in human umbilical vein endothelial cells. Cytokine 24:67-73 (Pubitemid 37324033)
26. Li S, Takeuchi F, Wang JA, Fuller C, Pacheco-Rodriguez G, Moss J, Darling TN (2005) MCP-1 overexpressed in tuberous sclerosis lesions acts as a paracrine factor for tumor development. J Exp Med 202:617-624 (Pubitemid 41248413)
27. Folkman J (2003) Fundamental concepts of the angiogenic process. Curr Mol Med 3:643-651 (Pubitemid 37236406)
28. Bian XW, Chen JH, Jiang XF, Bai JS, Wang QL, Zhang X (2004) Angiogenesis as an immunopharmacologic target in inflammation and cancer. Int Immunopharmacol 4:1537-1547 (Pubitemid 39200602)
29. Marchetti M, Vignoli A, Russo L, Balducci D, Pagnoncelli M, Barbui T, Falanga A (2008) Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin. Thromb Res 121:637-645 (Pubitemid 351305285)
30. Bijnsdorp IV, Capriotti F, Kruyt FA, Losekoot N, Fukushima M, Griffioen AW, Thijssen VL, Peters GJ (2011) Thymidine phosphorylase in cancer cells stimulates human endothelial cell migration and invasion by the secretion of angiogenic factors. Br J Cancer 104:1185-1192
31. Boisen L, Drasbek KR, Pedersen AS, Kristensen P (2010) Evaluation of endothelial cell culture as a model system of vascular ageing. Exp Gerontol 45:779-787
32. Nanobashvili J, Jozkowicz A, Neumayer C, Fugl A, Sporn E, Polterauer P, Huk I (2003) Comparison of angiogenic potential of human microvascular endothelial cells and human umbilical vein endothelial cells. Eur Surg 35:214-218 (Pubitemid 38283000)
33. Nunez MJ, Novio S, Balboa J, Seoane J, Suarez JA, Freire-Garabal M (2010) Effects of resveratrol on expression of vascular endothelial growth factor in human gingival fibroblasts stimulated by periodontal pathogens. Acta Odontol Scand 68:239-247
34. Knobloch J, Sibbing B, Jungck D, Lin Y, Urban K, Stoelben E, Strauch J, Koch A (2010) Resveratrol impairs the release of steroid-resistant inflammatory cytokines from human airway smooth muscle cells in chronic obstructive pulmonary disease. J Pharmacol Exp Ther 335:788-798
35. Gauliard B, Grieve D, Wilson R, Crozier A, Jenkins C, Mullen WD, Lean M (2008) The effects of dietary phenolic compounds on cytokine and antioxidant production by A549 cells. J Med Food 11:382-384 (Pubitemid 351948179)
36. Trapp V, Parmakhtiar B, Papazian V, Willmott L, Fruehauf JP (2010) Anti-angiogenic effects of resveratrol mediated by decreased VEGF and increased TSP1 expression in melanoma-endothelial cell co-culture. Angiogenesis 13:305-315
37. Belleri M, Ribatti D, Nicoli S, Cotelli F, Forti L, Vannini V, Stivala LA, Presta M (2005) Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4′- trimethoxystilbene. Mol Pharmacol 67:1451-1459 (Pubitemid 40594144)
38. Bertl E, Becker H, Eicher T, Herhaus C, Kapadia G, Bartsch H, Gerhauser C (2004) Inhibition of endothelial cell functions by novel potential cancer chemopreventive agents. Biochem Biophys Res Commun 325:287-295 (Pubitemid 39441191)
39. Cao L, Liu H, Lam DS, Yam GH, Pang CP (2010) In vitro screening for angiostatic potential of herbal chemicals. Invest Ophthalmol Vis Sci 51:6658-6664
40. Wang H, Zhou H, Zou Y, Liu Q, Guo C, Gao G, Shao C, Gong Y (2010) Resveratrol modulates angiogenesis through the GSK3beta/beta-catenin/TCF- dependent pathway in human endothelial cells. Biochem Pharmacol 80:1386-1395
41. Stivala LA, Savio M, Carafoli F, Perucca P, Bianchi L, Maga G, Forti L, Pagnoni UM, Albini A, Prosperi E, Vannini V (2001) Specific structural determinants are responsible for the antioxidant activity and the cell cycle effects of resveratrol. J Biol Chem 276:22586-22594
42. Horvath Z, Murias M, Saiko P, Erker T, Handler N, Madlener S, Jaeger W, Grusch M, Fritzer-Szekeres M, Krupitza G, Szekeres T (2006) Cytotoxic and biochemical effects of 3,3′,4,4′,5,5′-hexahydroxystilbene, a novel resveratrol analog in HL-60 human promyelocytic leukemia cells. Exp Hematol 34:1377-1384 (Pubitemid 44374836)
43. Saiko P, Pemberger M, Horvath Z, Savinc I, Grusch M, Handler N, Erker T, Jaeger W, Fritzer-Szekeres M, Szekeres T (2008) Novel resveratrol analogs induce apoptosis and cause cell cycle arrest in HT29 human colon cancer cells: inhibition of ribonucleotide reductase activity. Oncol Rep 19:1621-1626
44. Lin CM, Chang H, Chen YH, Li SY, Wu IH, Chiu JH (2006) Protective role of wogonin against lipopolysaccharide-induced angiogenesis via VEGFR-2, not VEGFR-1. Int Immunopharmacol 6:1690-1698 (Pubitemid 44344541)
45. Chen Y, Zhang YX, Li MH, Zhao WM, Shi YH, Miao ZH, Zhang XW, Lin LP, Ding J (2005) Antiangiogenic activity of 11,11′-dideoxyverticillin, a natural product isolated from the fungus Shiraia bambusicola. Biochem Biophys Res Commun 329:1334-1342 (Pubitemid 40568716)
46. Kanno S, Oda N, Abe M, Terai Y, Ito M, Shitara K, Tabayashi K, Shibuya M, Sato Y (2000) Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells. Oncogene 19:2138-2146 (Pubitemid 30251379)
47. Murias M, Luczak MW, Niepsuj A, Krajka-Kuzniak V, Zielinska-Przyjemska M, Jagodzinski PP, Jager W, Szekeres T, Jodynis-Liebert J (2008) Cytotoxic activity of 3,3′,4,4′,5,5′-hexahydroxystilbene against breast cancer cells is mediated by induction of p53 and downregulation of mitochondrial superoxide dismutase. Toxicol In Vitro 22:1361-1370
48. Ivison SM, Wang C, Himmel ME, Sheridan J, Delano J, Mayer ML, Yao Y, Kifayet A, Steiner TS (2010) Oxidative stress enhances IL-8 and inhibits CCL20 production from intestinal epithelial cells in response to bacterial flagellin. Am J Physiol Gastrointest Liver Physiol 299:G733-G741
49. Kosmidou I, Xagorari A, Roussos C, Papapetropoulos A (2001) Reactive oxygen species stimulate VEGF production from C(2)C(12) skeletal myotubes through a PI3 K/Akt pathway. Am J Physiol Lung Cell Mol Physiol 280:L585-L592
50. Witowski J, Ksiazek K, Jorres A (2008) Glucose-induced mesothelial cell senescence and peritoneal neoangiogenesis and fibrosis. Perit Dial Int 28(Suppl 5):S34-S37
51. Jayne D (2007) Molecular biology of peritoneal carcinomatosis. Cancer Treat Res 134:21-33
52. Kim YL (2009) Update on mechanisms of ultrafiltration failure. Perit Dial Int 29(Suppl 2):S123-S127
53. Ha H, Cha MK, Choi HN, Lee HB (2002) Effects of peritoneal dialysis solutions on the secretion of growth factors and extracellular matrix proteins by human peritoneal mesothelial cells. Perit Dial Int 22:171-177 (Pubitemid 34546327)
54. Rahman I, Biswas SK, Kirkham PA (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem Pharmacol 72:1439-1452 (Pubitemid 44666744)
55. Davies SJ, Mushahar L, Yu Z, Lambie M (2011) Determinants of peritoneal membrane function over time. Semin Nephrol 31:172-182
56. Ksiazek K, Breborowicz A, Jorres A, Witowski J (2007) Oxidative stress contributes to accelerated development of the senescent phenotype in human peritoneal mesothelial cells exposed to high glucose. Free Radic Biol Med 42:636-641 (Pubitemid 46205146)
57. Yao Q, Pawlaczyk K, Ayala ER, Styszynski A, Breborowicz A, Heimburger O, Qian JQ, Stenvinkel P, Lindholm B, Axelsson J (2008) The role of the TGF/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. Nephron Exp Nephrol 109:e71-e78
58. Ksiazek K, Korybalska K, Jorres A, Witowski J (2007) Accelerated senescence of human peritoneal mesothelial cells exposed to high glucose: the role of TGF-beta1. Lab Invest 87:345-356 (Pubitemid 46474562)
59. Paulitschke V, Schicher N, Szekeres T, Jager W, Elbling L, Riemer AB, Scheiner O, Trimurtulu G, Venkateswarlu S, Mikula M, Swoboda A, Fiebiger E, Gerner C, Pehamberger H, Kunstfeld R (2010) 3,3′,4,4′,5,5′- hexahydroxystilbene impairs melanoma progression in a metastatic mouse model. J Invest Dermatol 130:1668-1679